FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mirjam Heemskerk

Research Profile

Chemicals & Drugs

Anatomy

Physiology

Living Beings

Procedures

Devices

Gene Transfer Techniques

Co-author Network

Publications

TOP 3
Pleun Hombrink; Michel Kester; Harm Nijveen; Cornelis A M van Bergen; Arnoud de Ru; Jan W Drijfhout; J H Frederik Falkenburg; Chopie Hassan; Mirjam H M Heemskerk; Peter van Veelen
Discovery of T cell epitopes implementing HLA-peptidomics into a reverse immunology approach.
Stefani Spranger; Lilian Stärck; Wolfgang Uckert; Susanne Wilde; Mirjam H M Heemskerk; Irmela Jeremias; Matthias Leisegang; Barbara Mosetter; Dolores J Schendel; Bernhard Frankenberger
TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo.
Willem J J Falkenburg; Emma Gostick; Renate S Hagedoorn; Mirjam H M Heemskerk; Pleun Hombrink; Michel Kester; J Joseph Melenhorst; David A Price; Marian van de Meent; A John Barrett; J H Frederik Falkenburg; Inge Jedema
Allogeneic HLA-A*02-restricted WT1-specific T cells from mismatched donors are highly reactive but show off-target promiscuity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mirjam Heemskerk (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pleun Hombrink; Michel Kester; Harm Nijveen; Cornelis A M van Bergen; Arnoud de Ru; Jan W Drijfhout; J H Frederik Falkenburg; Chopie Hassan; Mirjam H M Heemskerk; Peter van Veelen
Discovery of T cell epitopes implementing HLA-peptidomics into a reverse immunology approach.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(8):3869-77.
2012: Stefani Spranger; Lilian Stärck; Wolfgang Uckert; Susanne Wilde; Mirjam H M Heemskerk; Irmela Jeremias; Matthias Leisegang; Barbara Mosetter; Dolores J Schendel; Bernhard Frankenberger
TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo.
Blood 2012;119(15):3440-9.
2011: Willem J J Falkenburg; Emma Gostick; Renate S Hagedoorn; Mirjam H M Heemskerk; Pleun Hombrink; Michel Kester; J Joseph Melenhorst; David A Price; Marian van de Meent; A John Barrett; J H Frederik Falkenburg; Inge Jedema
Allogeneic HLA-A*02-restricted WT1-specific T cells from mismatched donors are highly reactive but show off-target promiscuity.
Journal of immunology (Baltimore, Md. : 1950) 2011;187(5):2824-33.
2011: Avital L Amir; Renate de Boer; Arnoud de Ru; J H Frederik Falkenburg; Marieke Griffioen; Renate S Hagedoorn; Pieter S Hiemstra; Inge Jedema; Michel D G Kester; Gert-Jan Lugthart; Dirk M van der Steen; Cees van Kooten; Marleen M van Loenen; Peter van Veelen; Mirjam H M Heemskerk
PRAME-specific Allo-HLA-restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transfer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(17):5615-25.
2011: Marleen M van Loenen; Renate S Hagedoorn; Renate de Boer; Esther H M van Egmond; J H Frederik Falkenburg; Mirjam H M Heemskerk
Rapid re-expression of retrovirally introduced versus endogenous TCRs in engineered T cells after antigen-specific stimulation.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2011;34(2):165-74.
2011: Marleen M van Loenen; Renate de Boer; Renate S Hagedoorn; Esther H M van Egmond; J H Frederik Falkenburg; Mirjam H M Heemskerk
Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies.
Haematologica 2011;96(3):477-81.
2011: Kirsten B J Scholten; Annelies W Turksma; Muriel van den Hende; Sjoerd H van der burg; Mirjam H M Heemskerk; Chris J L M Meijer; Janneke J Ruizendaal; Erik Hooijberg
Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer.
Journal of translational medicine 2011;9():147.
2011: Pleun Hombrink; Michel Kester; Schumacher Ton; Peter A von dem Borne; Arne Bakker; J H Frederik Falkenburg; Sine Reker Hadrup; Mirjam H M Heemskerk
High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations.
PloS one 2011;6(8):e22523.
2010: Marleen M van Loenen; Renate de Boer; Avital L Amir; Renate S Hagedoorn; Gerdien L Volbeda; Roelof Willemze; Jon van Rood; J H Frederik Falkenburg; Mirjam H M Heemskerk
Mixed T cell receptor dimers harbor potentially harmful neoreactivity.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(24):10972-7.
2010: Avital L Amir; Lloyd J A D'Orsogna; Dave L Roelen; Marleen M van Loenen; Renate S Hagedoorn; Renate de Boer; Menno A W G van der Hoorn; Michel Kester; Ilias I N Doxiadis; J H Frederik Falkenburg; Frans H J Claas; Mirjam H M Heemskerk
Allo-HLA reactivity of virus-specific memory T cells is common.
Blood 2010;115(15):3146-57.
2010: Yi Zhang; Yeuying Liu; Kelly M Moxley; Lucy Golden-Mason; Michael G Hughes; Tongxin Liu; Mirjam H M Heemskerk; Hugo R Rosen; Michael I Nishimura
Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.
PLoS pathogens 2010;6(7):e1001018.
2010: Mirjam H M Heemskerk
T-cell receptor gene transfer for the treatment of leukemia and other tumors.
Haematologica 2010;95(1):15-9.
2009: L J D'Orsogna; A L Amir; Yvonne M Zoet; P M W van der Meer-Prins; Arno R van der Slik; Michel Kester; Mirjam H M Heemskerk; I I N Doxiadis; Dave L Roelen; F H J Claas
New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire.
Tissue antigens 2009;74(4):290-7.
2009: Katharina Pfistershammer; Anita Lawitschka; Christoph Klauser; Judith Leitner; Roman Weigl; Mirjam H M Heemskerk; Winfried F Pickl; Otto Majdic; Georg A Böhmig; Gottfried F Fischer; Hildegard T Greinix; Peter Steinberger
Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients.
Blood 2009;114(11):2323-32.
2009: Marieke Griffioen; Esther H M van Egmond; Michel Kester; Roel Willemze; J H Frederik Falkenburg; Mirjam H M Heemskerk
Retroviral transfer of human CD20 as a suicide gene for adoptive T-cell therapy.
Haematologica 2009;94(9):1316-20.
2009: Pim L J van der Heiden; Renate de Boer; Dirk M van der Steen; Michel Kester; Menno W A G van der Hoorn; Wilmy M E Haarman; Helen E Barnby-Porritt; Jeremy W Fry; C E Napper; Erik W A Marijt; Roel Willemze; J H Frederik Falkenburg; Mirjam H M Heemskerk
Identification of varicella-zoster virus-specific CD8 T cells in patients after T-cell-depleted allogeneic stem cell transplantation.
Journal of virology 2009;83(14):7361-4.
2009: Marleen M van Loenen; Renate S Hagedoorn; Michel Kester; Manja Hoogeboom; Roel Willemze; J H Frederik Falkenburg; Mirjam H M Heemskerk
Kinetic preservation of dual specificity of coprogrammed minor histocompatibility antigen-reactive virus-specific T cells.
Cancer research 2009;69(5):2034-41.
2009: Lars T van der Veken; Miriam Coccoris; Erwin Swart; J H Frederik Falkenburg; Schumacher Ton; Mirjam H M Heemskerk
Alpha beta T cell receptor transfer to gamma delta T cells generates functional effector cells without mixed TCR dimers in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(1):164-70.
2009: Lars T van der Veken; Maria Diez Campelo; Menno A W G van der Hoorn; Renate S Hagedoorn; H M Esther van Egmond; Jeroen van Bergen; Roel Willemze; J H Frederik Falkenburg; Mirjam H M Heemskerk
Functional analysis of killer Ig-like receptor-expressing cytomegalovirus-specific CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(1):92-101.
2008: Jennifer M L Tjon; Wieke H M Verbeek; Yvonne M C Kooy-Winkelaar; Binh H Nguyen; Arno R van der Slik; Allan Thompson; Mirjam H M Heemskerk; Marco W J Schreurs; Liesbeth H A Dekking; Chris J Mulder; Jeroen Van Bergen; Frits Koning
Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma.
Blood 2008;112(13):5103-10.
2008: Marieke Griffioen; H M Esther van Egmond; Helen Barnby-Porritt; Menno A W G van der Hoorn; Renate S Hagedoorn; Michel Kester; Nikolai Schwabe; Roel Willemze; J H Frederik Falkenburg; Mirjam H M Heemskerk
Genetic engineering of virus-specific T cells with T-cell receptors recognizing minor histocompatibility antigens for clinical application.
Haematologica 2008;93(10):1535-43.
2008: C E Rutten; S A P van Luxemburg-Heijs; Marieke Griffioen; Erik W A Marijt; Inge Jedema; Mirjam H M Heemskerk; Eduardus F M Posthuma; Rein Willemze; J H Frederik Falkenburg
HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia.
Leukemia 2008;22(7):1387-94.
2008: Danijela Koppers-Lalic; Marieke C Verweij; Andrea D Lipińska; Ying Wang; Edwin Quinten; Eric Reits; Joachim Koch; Sandra Loch; Marisa Marcondes Rezende; Franz Daus; Krystyna Bieńkowska-Szewczyk; Nikolaus Osterrieder; Thomas C Mettenleiter; Mirjam H M Heemskerk; Robert Tampé; Jacques Neefjes; Shafiqul I Chowdhury; Maaike E Ressing; F A M Rijsewijk; Emmanuel J H J Wiertz
Varicellovirus UL 49.5 proteins differentially affect the function of the transporter associated with antigen processing, TAP.
PLoS pathogens 2008;4(5):e1000080.
2008: Marja C J A van Eggermond; Ilhan Tezcan; Mirjam H M Heemskerk; Peter J van den Elsen
Transcriptional silencing of RFXAP in MHC class II-deficiency.
Molecular immunology 2008;45(10):2920-8.
2008: Arnold H Bakker; Rieuwert Hoppes; Carsten Linnemann; Mireille Toebes; Boris Rodenko; Celia R Berkers; Sine Reker Hadrup; Wim J E van Esch; Mirjam H M Heemskerk; Huib Ovaa; Schumacher Ton
Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(10):3825-30.
2008: Mirjam H M Heemskerk; Marieke Griffioen; J H Frederik Falkenburg
T-cell receptor gene transfer for treatment of leukemia.
Cytotherapy 2008;10(2):108-15.
2008: M M Waanders; S Heidt; Karin M Koekkoek; Yvonne M Zoet; Ilias Doxiadis; A Amir; Mirjam H M Heemskerk; Arend Mulder; A Brand; Dave L Roelen; Frans H J Claas
Monitoring of indirect allorecognition: wishful thinking or solid data?
Tissue antigens 2008;71(1):1-15.
2007: Jeltje F de Vries; Peter A von dem Borne; S A P van Luxemburg-Heijs; Mirjam H M Heemskerk; Rein Willemze; J H Frederik Falkenburg; Renée M Y Barge
Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing.
Haematologica 2007;92(12):1671-8.
2007: Anja U van Lent; Maho Nagasawa; Marleen M van Loenen; Remko Schotte; Schumacher Ton; Mirjam H M Heemskerk; Hergen Spits; Nicolas Legrand
Functional human antigen-specific T cells produced in vitro using retroviral T cell receptor transfer into hematopoietic progenitors.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(8):4959-68.
2007: Cornelis A M van Bergen; Michel Kester; Inge Jedema; Mirjam H M Heemskerk; S A P van Luxemburg-Heijs; Freke M Kloosterboer; W A Erik Marijt; Arnoud de Ru; M Ronald Schaafsma; Rein Willemze; Peter van Veelen; J H Frederik Falkenburg
Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene.
Blood 2007;109(9):4089-96.
2007: Jeltje F de Vries; L J Wammes; Inge Jedema; L van Dreunen; Bart A Nijmeijer; Mirjam H M Heemskerk; Rein Willemze; J H Frederik Falkenburg; Renée M Y Barge
Involvement of caspase-8 in chemotherapy-induced apoptosis of patient derived leukemia cell lines independent of the death receptor pathway and downstream from mitochondria.
Apoptosis : an international journal on programmed cell death 2007;12(1):181-93.
2007: Mirjam H M Heemskerk; Renate S Hagedoorn; Menno A W G van der Hoorn; Lars T van der Veken; Manja Hoogeboom; Michel Kester; Rein Willemze; J H Frederik Falkenburg
Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex.
Blood 2007;109(1):235-43.
2006: Daniel Sommermeyer; Julia Neudorfer; Monika Weinhold; Matthias Leisegang; Boris Engels; Elfriede Noessner; Mirjam H M Heemskerk; Jehad Charo; Dolores Schendel; Thomas Blankenstein; Helga Bernhard; Wolfgang Uckert
Designer T cells by T cell receptor replacement.
European journal of immunology 2006;36(11):3052-9.
2006: Ester M M van Leeuwen; Ester B M Remmerswaal; Mirjam H M Heemskerk; Ineke J M ten Berge; René A W van Lier
Strong selection of virus-specific cytotoxic CD4+ T-cell clones during primary human cytomegalovirus infection.
Blood 2006;108(9):3121-7.
2006: Chantal Eijsink; Michel Kester; Marry E I Franke; Kees L M C Franken; Mirjam H M Heemskerk; Frans H J Claas; Arend Mulder
Rapid assessment of the antigenic integrity of tetrameric HLA complexes by human monoclonal HLA antibodies.
Journal of immunological methods 2006;315(1-2):153-61.
2006: Frans H J Claas; Dave L Roelen; Arend Mulder; Ilias Doxiadis; Machteld Oudshoorn; Mirjam H M Heemskerk
Differential immunogenicity of HLA class I alloantigens for the humoral versus the cellular immune response: "towards tailor-made HLA mismatching".
Human immunology 2006;67(6):424-9.
2006: Peter A von dem Borne; S A P van Luxemburg-Heijs; Mirjam H M Heemskerk; Inge Jedema; Arend Mulder; Rein Willemze; J H Frederik Falkenburg
Molecular persistence of chronic myeloid leukemia caused by donor T cells specific for lineage-restricted maturation antigens not recognizing immature progenitor-cells.
Leukemia 2006;20(6):1040-6.
2006: Mirjam H M Heemskerk
Optimizing TCR gene transfer.
Clinical immunology (Orlando, Fla.) 2006;119(2):121-2.
2006: Lars T van der Veken; Renate S Hagedoorn; Marleen M van Loenen; Rein Willemze; J H Frederik Falkenburg; Mirjam H M Heemskerk
Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity.
Cancer research 2006;66(6):3331-7.
2006: Yves Chalandon; Sylvie Degermann; Jean Villard; Lionel Arlettaz; Laurent Kaiser; Solange Vischer; Steffen Walter; Mirjam H M Heemskerk; René A W van Lier; Claudine Helg; Bernard Chapuis; Eddy Roosnek
Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications.
Blood 2006;107(1):389-96.
2005: Lars T van der Veken; Manja Hoogeboom; Roelof A de Paus; Rein Willemze; J H Frederik Falkenburg; Mirjam H M Heemskerk
HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity.
Gene therapy 2005;12(23):1686-95.
2005: Arend Mulder; Chantal Eijsink; Michel Kester; Marry E I Franke; Marrie J Kardol; Mirjam H M Heemskerk; Cees van Kooten; Frank A W Verreck; Jan Wouter Drijfhout; Frits Koning; Ilias Doxiadis; Frans H J Claas
Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(9):5950-7.
2005: Bregje Mommaas; Astrid G S van Halteren; Jos Pool; Lars T van der Veken; Brigitte Wieles; Mirjam H M Heemskerk; Els Goulmy
Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer.
Haematologica 2005;90(10):1415-21.
2005: Yvonne M Zoet; Chantal Eijsink; Marrie J Kardol; Marry E I Franke-van Dijk; G Louis Wilson; Roelof A de Paus; Eric Mickelson; Mirjam H M Heemskerk; Peter J van den Elsen; Frans H J Claas; Arend Mulder; Ilias Doxiadis
The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies.
Human immunology 2005;66(5):519-25.
2005: FM van Dunné; C J M Doggen; Mirjam H M Heemskerk; Frits R Rosendaal; Frans M Helmerhorst
Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis.
Human reproduction (Oxford, England) 2005;20(3):802-6.
2004: Mirjam H M Heemskerk; Manja Hoogeboom; Renate S Hagedoorn; Michel Kester; Rein Willemze; J H Frederik Falkenburg
Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer.
The Journal of experimental medicine 2004;199(7):885-94.
2003: Mirjam H M Heemskerk; Manja Hoogeboom; Roelof A de Paus; Michel Kester; Menno A W G van der Hoorn; Els Goulmy; Rein Willemze; J H Frederik Falkenburg
Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region.
Blood 2003;102(10):3530-40.
2003: W A Erik Marijt; Mirjam H M Heemskerk; Freke M Kloosterboer; Els Goulmy; Michel Kester; Menno A W G van der Hoorn; Simone A P van Luxemburg-Heys; Manja Hoogeboom; Tuna Mutis; Jan Wouter Drijfhout; Jon van Rood; Rein Willemze; J H Frederik Falkenburg
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(5):2742-7.
2002: J H Frederik Falkenburg; W A Erik Marijt; Mirjam H M Heemskerk; Rein Willemze
Minor histocompatibility antigens as targets of graft-versus-leukemia reactions.
Current opinion in hematology 2002;9(6):497-502.
2002: Willy A Noort; Alwine B Kruisselbrink; Pieternella S in't Anker; Marjolein Kruger; Rutger L van Bezooijen; Roelof A de Paus; Mirjam H M Heemskerk; Clemens W G M Löwik; J H Frederik Falkenburg; Rein Willemze; Willem E Fibbe
Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.
Experimental hematology 2002;30(8):870-8.
2002: Marjan J T Veuger; Mirjam H M Heemskerk; M Willy Honders; Rein Willemze; Renée M Y Barge
Functional role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells.
Blood 2002;99(4):1373-80.
2002: Tuna Mutis; Kamran Ghoreschi; Ellen Schrama; Janine Kamp; Mirjam H M Heemskerk; J H Frederik Falkenburg; Martina Wilke; Els Goulmy
Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(8):412-9.
2001: Mirjam H M Heemskerk; Roelof A de Paus; Ellie G A Lurvink; Frits Koning; Arend Mulder; Rein Willemze; Jon van Rood; J H Frederik Falkenburg
Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(12):6806-11.
1999: AC Jaleco; AP Stegmann; Mirjam H M Heemskerk; Franka Couwenberg; Arjen Q Bakker; Kees Weijer; Hergen Spits
Genetic modification of human B-cell development: B-cell development is inhibited by the dominant negative helix loop helix factor Id3.
Blood 1999;94(8):2637-46.
1999: IS Weimar; Kees Weijer; Paul van den Berk; EJ Muller; N Miranda; Arjen Q Bakker; Mirjam H M Heemskerk; A Hekman; Gijsbert C De Gast; Winald Gerritsen
HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
British journal of cancer 1999;81(1):43-53.
1999: Mirjam H M Heemskerk; Erik Hooijberg; Janneke J Ruizendaal; M M van der Weide; Esther W M Kueter; Arjen Q Bakker; Schumacher Ton; Hergen Spits
Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells.
Cellular immunology 1999;195(1):10-7.
1999: Bianca Blom; Mirjam H M Heemskerk; M C M Verschuren; Jacques J M van Dongen; AP Stegmann; Arjen Q Bakker; Franka Couwenberg; PC Res; Hergen Spits
Disruption of alpha beta but not of gamma delta T cell development by overexpression of the helix-loop-helix protein Id3 in committed T cell progenitors.
The EMBO journal 1999;18(10):2793-802.
1999: Bianca Blom; M C M Verschuren; Mirjam H M Heemskerk; Arjen Q Bakker; Ellen J van Gastel-Mol; Ingrid L M Wolvers-Tettero; Jacques J M van Dongen; Hergen Spits
TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation.
Blood 1999;93(9):3033-43.
1998: Hergen Spits; Bianca Blom; AC Jaleco; Kees Weijer; M C M Verschuren; Jacques J M van Dongen; Mirjam H M Heemskerk; PC Res
Early stages in the development of human T, natural killer and thymic dendritic cells.
Immunological reviews 1998;165():75-86.
1997: Mirjam H M Heemskerk; Bianca Blom; G Nolan; AP Stegmann; Arjen Q Bakker; Kees Weijer; PC Res; Hergen Spits
Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3.
The Journal of experimental medicine 1997;186(9):1597-602.
1990: W Martin Kast; J A Bluestone; Mirjam H M Heemskerk; J Spaargaren; A C Voordouw; J D Ellenhorn; Cornelis J M Melief
Treatment with monoclonal anti-CD3 antibody protects against lethal Sendai virus infection by induction of natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(7):2254-9.